53 results
8-K
EX-99.1
AMPE
Ampio Pharmaceuticals Inc
15 Sep 21
Other Events
9:25am
severe OAK, for which Ampion is indicated.
As a result of the COVID-19 pandemic, the FDA recommended that the Company identify subject information … that was impacted by the pandemic during the AP-013 clinical study and conduct a sensitivity analysis to detect potential biases related to the pandemic
424B5
hm5 wfhusr
14 Dec 21
Prospectus supplement for primary offering
5:06pm
424B5
ppu3tp u75s9k2
6 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
kl0g7nvfwzsds0bhdz
24 Mar 20
Other Events
8:32am
8-K
EX-99.1
ap1m6 tlr4
20 Apr 22
Ampio Provides Regulatory Update
9:43pm
8-K
s2y1q5phb bwdodls43
24 Mar 20
Other Events
8:32am
8-K
EX-99.1
2f7th1qk
29 Dec 20
Other Events
4:17pm
8-K
EX-99.1
v4pivf8obopks4m9oxi
3 Mar 21
Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
ln4v5jh5iw
29 Mar 22
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
4:17pm
8-K
90uxr
28 Apr 22
Conference Call Script
8:00am
8-K
EX-99.1
nwuldr
5 May 21
Results of Operations and Financial Condition
4:05pm